Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Monotherapy After Coronary Stenting in Acute Myocardial Infarction
NCT05149560Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Dec 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ticagrelor in acute myocardial infarction (AMI), sponsored by Region Västra Götaland. Primary endpoint: Major Adverse Cardiac Event at 3 months. Started Dec 2021; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT05149560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05149560.